B.R. Jaeger

1.2k total citations
36 papers, 806 citations indexed

About

B.R. Jaeger is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, B.R. Jaeger has authored 36 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 18 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in B.R. Jaeger's work include Lipoproteins and Cardiovascular Health (11 papers), Transplantation: Methods and Outcomes (7 papers) and Blood properties and coagulation (6 papers). B.R. Jaeger is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Transplantation: Methods and Outcomes (7 papers) and Blood properties and coagulation (6 papers). B.R. Jaeger collaborates with scholars based in Germany, United States and United Kingdom. B.R. Jaeger's co-authors include D. Seidel, Carlos A. Labarrere, Wolfgang Ramlow, E. Roeseler, Franz Heigl, Anja Vogt, Carlos A. Labarrere, Klaus G. Parhofer, Michael Koch and Dorothea Nagel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Stroke.

In The Last Decade

B.R. Jaeger

36 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.R. Jaeger Germany 16 517 308 131 107 100 36 806
Gianluigi Scannapieco Italy 16 256 0.5× 499 1.6× 44 0.3× 122 1.1× 77 0.8× 49 1.0k
Kasper Mønsted Pedersen Denmark 13 265 0.5× 130 0.4× 223 1.7× 89 0.8× 76 0.8× 31 730
Senta Graf Austria 19 269 0.5× 726 2.4× 58 0.4× 102 1.0× 56 0.6× 71 1.2k
Enver Atalar Türkiye 18 229 0.4× 802 2.6× 58 0.4× 56 0.5× 88 0.9× 57 1.2k
Małgorzata Konieczyńska Poland 16 109 0.2× 255 0.8× 94 0.7× 62 0.6× 98 1.0× 59 769
Shinichiro Doi Japan 23 304 0.6× 479 1.6× 61 0.5× 13 0.1× 42 0.4× 110 1.6k
Spyros Aslanidis Greece 20 171 0.3× 164 0.5× 41 0.3× 93 0.9× 173 1.7× 45 1.0k
Keizo Furukawa Japan 19 255 0.5× 352 1.1× 36 0.3× 78 0.7× 21 0.2× 61 947
Mikkel Malby Schoos Denmark 16 340 0.7× 817 2.7× 166 1.3× 39 0.4× 55 0.6× 57 1.2k
Akira Taruya Japan 18 699 1.4× 604 2.0× 35 0.3× 38 0.4× 139 1.4× 65 1.2k

Countries citing papers authored by B.R. Jaeger

Since Specialization
Citations

This map shows the geographic impact of B.R. Jaeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.R. Jaeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.R. Jaeger more than expected).

Fields of papers citing papers by B.R. Jaeger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.R. Jaeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.R. Jaeger. The network helps show where B.R. Jaeger may publish in the future.

Co-authorship network of co-authors of B.R. Jaeger

This figure shows the co-authorship network connecting the top 25 collaborators of B.R. Jaeger. A scholar is included among the top collaborators of B.R. Jaeger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.R. Jaeger. B.R. Jaeger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baig, Abdul Mannan, et al.. (2024). Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols. Inflammopharmacology. 32(4). 2075–2090. 2 indexed citations
2.
Kell, Douglas B., et al.. (2024). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease. Frontiers in Immunology. 15. 1386607–1386607. 31 indexed citations
3.
Jaeger, B.R., et al.. (2022). The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19. Frontiers in Cardiovascular Medicine. 9. 1007636–1007636. 9 indexed citations
4.
Grupp, Clemens, Stephen Zewinger, Bernd Hohenstein, et al.. (2020). Relapsing and Progressive Complications of Severe Hypertriglyceridemia: Effective Long-Term Treatment with Double Filtration Plasmapheresis. Blood Purification. 49(4). 457–467. 15 indexed citations
5.
Hohenstein, Bernd, Ulrich Julius, Peter Lansberg, et al.. (2017). Rationale and design of MultiSELECt: A European Multi center S tudy on the E ffect of L ipoprotein(a) E limination by lipoprotein apheresis on C ardiovascular ou t comes. Atherosclerosis Supplements. 30. 180–186. 23 indexed citations
6.
Schettler, Volker, C. Neumann, Christian Peter, et al.. (2017). Current insights into the German Lipoprotein Apheresis Registry (GLAR) – Almost 5 years on. Atherosclerosis Supplements. 30. 50–55. 19 indexed citations
7.
Labarrere, Carlos A. & B.R. Jaeger. (2012). Biomarkers of heart transplant rejection: the good, the bad, and the ugly!. Translational research. 159(4). 238–251. 30 indexed citations
8.
Labarrere, Carlos A., John R. Woods, James W. Hardin, et al.. (2012). Value of the First Post-Transplant Biopsy for Predicting Long-Term Cardiac Allograft Vasculopathy (CAV) and Graft Failure in Heart Transplant Patients. PLoS ONE. 7(4). e36100–e36100. 7 indexed citations
9.
Labarrere, Carlos A., John R. Woods, James W. Hardin, et al.. (2011). Early Prediction of Cardiac Allograft Vasculopathy and Heart Transplant Failure. American Journal of Transplantation. 11(3). 528–535. 55 indexed citations
10.
Schettler, Volker, B.R. Jaeger, & Reinhard Klingel. (2009). The German Lipid Apheresis Registry – remaining to be established. Atherosclerosis Supplements. 10(5). 59–61. 6 indexed citations
11.
Jaeger, B.R., Dorothea Nagel, Franz Heigl, et al.. (2009). Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events. Nature Reviews Cardiology. 6(3). 229–239. 225 indexed citations
12.
Thielmann, Matthias, Parwis Massoudy, B.R. Jaeger, et al.. (2006). Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery☆. European Journal of Cardio-Thoracic Surgery. 30(1). 117–125. 53 indexed citations
13.
Jaeger, B.R., Frank M. Bengel, Kenichi Odaka, et al.. (2005). Changes in Myocardial Vasoreactivity After Drastic Reduction of Plasma Fibrinogen and Cholesterol: a Clinical Study in Long-term Heart Transplant Survivors Using Positron Emission Tomography. The Journal of Heart and Lung Transplantation. 24(12). 2022–2030. 9 indexed citations
14.
Jaeger, B.R. & Carlos A. Labarrere. (2003). Fibrinogen und Atherothrombose: vulnerable Plaque oder vulnerabler Patient?. Herz. 28(6). 530–538. 14 indexed citations
15.
Jaeger, B.R., et al.. (2002). Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia. The Journal of Pediatrics. 141(1). 125–128. 11 indexed citations
16.
17.
Bosch, Thomas, et al.. (2001). Improvement of Hemorheology by DALI Apheresis: Acute Effects on Plasma Viscosity and Erythrocyte Aggregation in Hypercholesterolemic Patients. Therapeutic Apheresis. 5(5). 372–376. 34 indexed citations
18.
Jaeger, B.R.. (2001). Evidence for Maximal Treatment of Atherosclerosis: Drastic Reduction of Cholesterol and Fibrinogen Restores Vascular Homeostasis. Therapeutic Apheresis and Dialysis. 5(3). 207–211. 11 indexed citations
19.
Jaeger, B.R. & D. Seidel. (2001). Hyperlioproteinämie und LDL-AphereseKlinische Erfahrungen mit dem H.E.L.P.-System. Herz. 26(8). 531–544. 4 indexed citations
20.
Jaeger, B.R., Peter Marx, Thomas Pfefferkorn, Gerhard F. Hamann, & D. Seidel. (1999). Heparin-Mediated Extracorporeal LDL/Fibrinogen Precipitation —H.E.L.P.-In Coronary and Cerebral Ischemia. PubMed. 73. 81–84. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianluigi Scannapieco Breakdown of academic impact, for papers by Kasper Mønsted Pedersen Breakdown of academic impact, for papers by Senta Graf Breakdown of academic impact, for papers by Enver Atalar Breakdown of academic impact, for papers by Małgorzata Konieczyńska Breakdown of academic impact, for papers by Shinichiro Doi Breakdown of academic impact, for papers by Spyros Aslanidis Breakdown of academic impact, for papers by Keizo Furukawa Breakdown of academic impact, for papers by Mikkel Malby Schoos Breakdown of academic impact, for papers by Akira Taruya
Rankless by CCL
2026